Cellular Biomedicine (CBMG) 10-K2011 FY Annual report

Filed: 30 Mar 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: air, alternative, ambulance, Automobile, Bejing, bribery, burdensome, Cambium, Circular, commercial, consecutive, contractor, contractual, Corrupt, Corruption, disadvantage, duly, Eagle, extortion, face, fine, fraudulent, Golden, hereto, herewith, hinder, hindered, Huangwei, inadvertently, injunction, landlord, Learning, legislation, Lingyan, LongWen, manually, matter, maximum, Medical, monitoring, moving, organizational, OTC, OTCQB, PA, page, paralegal, partner, Philadelphia, photography, priority, prohibited, prohibiting, put, QTCQB, recycling, redacted, resell, resolve, seed, spouse, strayarrow, subcontract, theft, Translated, undersigned, unpredictable, unrelated, virtue, weighing, Zhe, Zhong

Removed: accredited, begun, Canada, cancelled, commonly, contract, demonstrated, dependant, Earning, environmentally, European, executed, exempted, extension, import, imposed, India, Macao, meeting, merging, offering, originally, practice, Rhino, Science, shrimp, Southeast, Taiwan, turn, Union

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CBMG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

I, Norm Klein, certify, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of EastBridge Investment Group Corporation for the fiscal year ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of EastBridge Investment Group Corporation.


	By:	/s/ Norm Klein

Date: March 30, 2012	Name:	Norm Klein
	Title:	Chief Financial Officer
		(Principal Financial Officer)